3 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow SB206 12%: new trials by email Literature Review of SB206 12% trials Research Report on SB206 12%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC SB206 12%, Placebo - Molluscum Contagiosum | Phase 3 | Completed | Novan, Inc. | 355 | 2019-06-13 | 2023-03-23 |
| A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1) SB206 12%, Placebo - Molluscum Contagiosum | Phase 3 | Completed | Novan, Inc. | 352 | 2019-06-03 | 2022-12-27 |
| A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum SB206 4%, SB206 8%, SB206 12% - Molluscum Contagiosum | Phase 2 | Completed | Novan, Inc. | 256 | 2018-01-24 | 2023-05-06 |
Novan, Inc. (3)
United States (3)
Adelaide Hebert, MD (1) · Amy Paller, MD (1) · Tomoko Maeda-Chubachi, MD (1)